Showing results (2251-2260 of 3,034) with videos related to
Sort By:
Pageof 304
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.Small (Weinheim an Der Bergstrasse, Germany)|July 26, 2023
A New Family of Layered Metal-Organic Semiconductors: Cu/V-OrganophosphonatesPatrik Tholen, Lukas Wagner, Jean G A Ruthes, et al.Journal of the American College of Surgeons|June 8, 1999
Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered technetium 99m sulphur colloid with overnight migration timeD J Winchester, S F Sener, D P Winchester, et al.Anticancer Research|August 6, 2000
Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in IsraelJ Iscovich, A Fischbein, J Fisher-Fischbein, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysisMaud Condomines, Dirk Hose, Pierre Raynaud, et al.Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.Frontiers in Bioengineering and Biotechnology|June 12, 2020
Pre-treatment Strategies for Value Addition in Poultry LitterTaís Carla Gaspareto, Thamarys Scapini, Bruno Venturin, et al.Pediatric Blood & Cancer|March 27, 2026
Patient Activation in Childhood, Adolescent, and Young Adult Cancer Survivors: Current Insights and Implications for Survivorship Care-A Systematic Review From the e-QuoL ProjectCharlotte Demoor-Goldschmidt, Anne Maas, Gisela Michel, et al.International Journal of Cancer|December 21, 2020
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trialDavey Daniel, Vladimer Kuchava, Igor Bondarenko, et al.Leukemia|April 25, 2020
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaHartmut Goldschmidt, Meletios A Dimopoulos, S Vincent Rajkumar, et al.Pageof 304